Hospira Told To Clean Up Manufacturing Process In India
Hospira Inc. is under fire from the U.S. Food and Drug Administration over allegedly unsanitary conditions at its pharmaceutical manufacturing facility in India that raise concerns about drug contamination, the company...To view the full article, register now.
Already a subscriber? Click here to view full article